INBRIJA is inhaled levodopa designed for use as needed when Parkinson's symptoms start to return. The return of symptoms is referred to as an "OFF episode," or an "OFF period."
In a clinical study, INBRIJA began to improve motor symptoms in as soon as 10 minutes and significantly improved them by 30 minutes. Individual results may vary.
Nobody knows your OFF periods better than you. Together, you and your doctor can set specific goals for managing your OFF periods.
Talk to your doctor about what you're going through. Share as much as you can. Use It Starts With You, a doctor discussion guide, to help you make the most of every minute, every time you see your doctor. Ask if INBRIJA may be right for you.
Before using INBRIJA, tell your healthcare provider about all your medical conditions, including:
Please see below for additional Important Safety Information.
These resources will help you better understand INBRIJA and how to use it appropriately:
When it comes to getting INBRIJA, you have Prescription Support Services.
If you and your doctor decide that INBRIJA is right for you and a prescription form is submitted by your doctor, here is what you should expect next:
After determining coverage, a specialist will call you to:
You must speak to the specialist who calls to get this information. Calls from the Prescription Support Services specialist will come from the phone number 1‑888‑887‑3447.
You must speak to the specialty pharmacy representative who calls to confirm your shipment. Calls may be from an unrecognized phone number.
If you need to change the schedule of your INBRIJA shipments, contact your specialty pharmacy to make arrangements.
Prescription Support Services can confirm whether your insurance will cover your prescription and whether you are eligible for our co‑pay assistance program. If you have commercial insurance (employer‑sponsored or individual) and INBRIJA is covered, you may be eligible for co‑pay assistance for INBRIJA, where allowed by law. Patients who participate in Medicaid, Medicare, or any other federal healthcare program are not eligible to receive co‑pay assistance.
If you have questions about INBRIJA, call Prescription Support Services toll free at 1‑888‑887‑3447. Specialists are available from
8 AM to 8 PM Eastern Time, Monday through Friday.
Resources to help you better understand OFF periods, INBRIJA and how to use it.
Fill out the form below to receive updates and to learn more about INBRIJA.
INBRIJA™ is a prescription medicine used for the return of Parkinson’s symptoms (known as OFF episodes) in adults treated with carbidopa‑levodopa medicines.
INBRIJA does not replace regular carbidopa‑levodopa medicines.
Do not use INBRIJA if you take or have taken a nonselective monoamine oxidase inhibitor such as phenelzine or tranylcypromine within the last 2 weeks.
INBRIJA is a prescription medicine used for the return of Parkinson’s symptoms (known as OFF episodes) in adults treated with carbidopa‑levodopa medicines. INBRIJA does not replace regular carbidopa‑levodopa medicines.
Do not use INBRIJA if you take or have taken a nonselective monoamine oxidase inhibitor such as phenelzine or tranylcypromine within the last 2 weeks.
Before using INBRIJA, tell your healthcare provider about all your medical conditions, including:
Tell your healthcare provider if you take:
Do not take more than 1 dose (2 capsules) for any OFF period. Do not take more than 5 doses (10 capsules) of INBRIJA in a day.
INBRIJA is for oral inhalation only. Do not swallow or open INBRIJA capsules.
Do not drive, operate machinery, or do other activities until you know how INBRIJA affects you. Sleepiness and falling asleep suddenly can happen as late as a year after treatment is started.
INBRIJA can cause serious side effects including the following. Tell your healthcare provider if you experience them:
The most common side effects of INBRIJA include cough, upper respiratory tract infection, nausea, and change in the color of saliva or spit.
Please see the Patient Information Leaflet.
